Racial variation in the advanced prostate cancer genome. Read more about Racial variation in the advanced prostate cancer genome.
Select black men are potential candidates for prostate hemi-ablation based on radical prostatectomy histopathology for intermediate-risk prostate cancer-a multicenter SEARCH cohort study. Read more about Select black men are potential candidates for prostate hemi-ablation based on radical prostatectomy histopathology for intermediate-risk prostate cancer-a multicenter SEARCH cohort study.
Delayed definitive management of localized prostate cancer: what do we know? Read more about Delayed definitive management of localized prostate cancer: what do we know?
Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer. Read more about Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer.
Addressing racial disparities in prostate cancer pathology prediction models: external validation and comparison of four models of pathological outcome prediction before radical prostatectomy in the multiethnic SEARCH cohort. Read more about Addressing racial disparities in prostate cancer pathology prediction models: external validation and comparison of four models of pathological outcome prediction before radical prostatectomy in the multiethnic SEARCH cohort.
Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration. Read more about Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration.
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Read more about A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC).
Correction to: Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide. Read more about Correction to: Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide.
Correction to: Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer. Read more about Correction to: Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer.
The state of focal therapy in the treatment of prostate cancer: the university of California collaborative (UC-Squared) consensus statement. Read more about The state of focal therapy in the treatment of prostate cancer: the university of California collaborative (UC-Squared) consensus statement.
